Titan Pharmaceuticals
TTNP
TTNP was delisted on the 1st of October, 2025.
35 hedge funds and large institutions have $5.47M invested in Titan Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 16 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
13% less funds holding
Funds holding: 40 → 35 (-5)
31% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 16
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
50% less capital invested
Capital invested by funds: $10.9M → $5.47M (-$5.41M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
+$782K |
| 2 |
Millennium Management
New York
|
+$595K |
| 3 |
WPA
Winning Points Advisors
Boca Raton,
Florida
|
+$381K |
| 4 |
ECM
Element Capital Management
New York
|
+$214K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$186K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.91M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$409K |
| 3 |
SO
STRS Ohio
Columbus,
Ohio
|
-$354K |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$180K |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$128K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
RhumbLine Advisers
Boston,
Massachusetts
| – | -$69K | -6 | Closed |
|
52
New York State Common Retirement Fund
Albany,
New York
| – | -$64K | -5 | Closed |
|
53
Stifel Financial
St. Louis,
Missouri
| – | -$62K | -5 | Closed |
|
|
PPA
54
Parametric Portfolio Associates
Seattle,
Washington
| – | -$44K | -4 | Closed |
|
55
SG Americas Securities
New York
| – | -$50K | -4 | Closed |
|
|
AIG
56
American International Group
New York
| – | -$38K | -3 | Closed |
|
|
NFA
57
Nationwide Fund Advisors
Columbus,
Ohio
| – | -$40K | -3 | Closed |
|
|
TRCT
58
Tower Research Capital (TRC)
New York
| – | -$13K | -1 | Closed |
|
|
AIP
59
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$5K | – | – |
|
60
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$3K | – | – |
|
TTNP Hedge Fund Activity: Q2 2017 in Review
35 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Titan Pharmaceuticals (TTNP) for Q2 2017, worth a combined $5.47M — down 50% from $10.9M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of TTNP and 11 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was Municipal Employees' Retirement System of Michigan, opening a new position worth an estimated $782K. The largest seller was BlackRock, cutting an estimated $1.91M.
- 35 institutional investors held Titan Pharmaceuticals (TTNP) as of Q2 2017, down from 40 in Q1 2017.
- Funds reported $5.47M of Titan Pharmaceuticals stock for Q2 2017, down 50% quarter-over-quarter.
- 11 funds opened new Titan Pharmaceuticals positions in Q2 2017 and 16 closed out, a net change of -5 holders.
- The largest Titan Pharmaceuticals buyer in Q2 2017 was Municipal Employees' Retirement System of Michigan, an estimated $782K added.
- The largest Titan Pharmaceuticals seller in Q2 2017 was BlackRock, an estimated $1.91M sold.
Based on aggregated 13F filings for Q2 2017.